163 related articles for article (PubMed ID: 38106558)
1. Intelligent prognosis evaluation system for stage I-III resected non-small-cell lung cancer patients on CT images: a multi-center study.
Zhang S; Liu X; Zhou L; Wang K; Shao J; Shi J; Wang X; Mu J; Gao T; Jiang Z; Chen K; Wang C; Wang G
EClinicalMedicine; 2023 Nov; 65():102270. PubMed ID: 38106558
[TBL] [Abstract][Full Text] [Related]
2. A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study.
Deng K; Wang L; Liu Y; Li X; Hou Q; Cao M; Ng NN; Wang H; Chen H; Yeom KW; Zhao M; Wu N; Gao P; Shi J; Liu Z; Li W; Tian J; Song J
EClinicalMedicine; 2022 Sep; 51():101541. PubMed ID: 35813093
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of machine learning models to predict survival of patients with resected stage-III NSCLC.
Jin L; Zhao Q; Fu S; Cao F; Hou B; Ma J
Front Oncol; 2023; 13():1092478. PubMed ID: 36994203
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
6. A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer.
Yang L; Fan X; Qin W; Xu Y; Zou B; Fan B; Wang S; Dong T; Wang L
Cancer Med; 2022 Nov; 11(22):4246-4255. PubMed ID: 35491970
[TBL] [Abstract][Full Text] [Related]
7. Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study.
Liu Y; Wang Y; Wang Y; Xie Y; Cui Y; Feng S; Yao M; Qiu B; Shen W; Chen D; Du G; Chen X; Liu Z; Li Z; Yang X; Liang C; Wu L
EClinicalMedicine; 2022 Oct; 52():101562. PubMed ID: 35928032
[TBL] [Abstract][Full Text] [Related]
8. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
9. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Zhong WZ; Wang Q; Mao WM; Xu ST; Wu L; Shen Y; Liu YY; Chen C; Cheng Y; Xu L; Wang J; Fei K; Li XF; Li J; Huang C; Liu ZD; Xu S; Chen KN; Xu SD; Liu LX; Yu P; Wang BH; Ma HT; Yan HH; Yang XN; Zhou Q; Wu YL;
Lancet Oncol; 2018 Jan; 19(1):139-148. PubMed ID: 29174310
[TBL] [Abstract][Full Text] [Related]
10. [Pathological staging criteria for carcinoma in the remnant stomach: an exploratory study].
Gao Z; Zhao X; Jiang K; Wang B; Li Y; Ye Y; Wang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):514-521. PubMed ID: 29774932
[TBL] [Abstract][Full Text] [Related]
11. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
[TBL] [Abstract][Full Text] [Related]
12. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
14. External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
Young KA; Efiong E; Dove JT; Blansfield JA; Hunsinger MA; Wild JL; Shabahang MM; Facktor MA
Ann Surg Oncol; 2017 Jun; 24(6):1459-1464. PubMed ID: 28168388
[TBL] [Abstract][Full Text] [Related]
15. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prognostic nomogram for resected non-small cell neuroendocrine tumor: A population-based respective study in China and the SEER database.
Liu Y; Yang M; Pang Z; Zhao X; Ma G; Zhao Q; Du J
Heliyon; 2023 Apr; 9(4):e15319. PubMed ID: 37089398
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
[TBL] [Abstract][Full Text] [Related]
18. Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study.
She Y; He B; Wang F; Zhong Y; Wang T; Liu Z; Yang M; Yu B; Deng J; Sun X; Wu C; Hou L; Zhu Y; Yang Y; Hu H; Dong D; Chen C; Tian J
EBioMedicine; 2022 Dec; 86():104364. PubMed ID: 36395737
[TBL] [Abstract][Full Text] [Related]
19. Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation.
Huang P; Illei PB; Franklin W; Wu PH; Forde PM; Ashrafinia S; Hu C; Khan H; Vadvala HV; Shih IM; Battafarano RJ; Jacobs MA; Kong X; Lewis J; Yan R; Chen Y; Housseau F; Rahmim A; Fishman EK; Ettinger DS; Pienta KJ; Wirtz D; Brock MV; Lam S; Gabrielson E
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077686
[TBL] [Abstract][Full Text] [Related]
20. Effect of epidermal growth factor receptor mutation on early-stage non-small cell lung cancer according to the 8th TNM classification.
Isaka T; Ito H; Nakayama H; Yokose T; Yamada K; Masuda M
Lung Cancer; 2020 Jul; 145():111-118. PubMed ID: 32428800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
